Physician

Yusuf Khan Deshmukh, M.D.

According to 2025 Medicare claims, Yusuf Deshmukh, M.D. (NPI: 1972585883) practices hematology/oncology in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is ELIZABETHTOWN HEMATOLOGY-ONCOLOGY PLC (NPI: 1730161688; TIN: 611273759) and primary practice location at 42701-2789.

Deshmukh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 486 traditional Medicare patients, billed 65,803 HCPCS/CPT codes, and received $1,550,083 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,647 prescription claims across 311 beneficiaries totaling $2,248,223 in drug costs, led by Revlimid (Lenalidomide). DME data shows 70 claims. Open Payments data shows 114 records totaling $2,327. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $392,255 to $1,550,083. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $710,959 to $2,248,223. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,665 to $4,884.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	445	32,504	$392,255
2016	400	22,020	$329,203
2017	481	21,534	$271,009
2018	426	38,177	$378,606
2019	463	32,685	$531,685
2020	415	34,198	$722,650
2021	468	40,835	$955,395
2022	487	51,451	$1,313,269
2023	496	54,315	$1,242,710
2024	486	65,803	$1,550,083

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	2,168	$710,959
2016	208	2,463	$946,161
2017	225	2,505	$1,041,509
2018	230	2,741	$1,267,521
2019	206	2,399	$1,227,593
2020	216	2,438	$1,663,341
2021	206	2,380	$2,335,168
2022	247	2,543	$2,583,838
2023	263	2,575	$2,028,867
2024	311	2,647	$2,248,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	55	321	$14,360
2016	31	224	$5,904
2017	14	119	$3,350
2018	11	83	$2,109
2019	N/R	122	$3,834
2020	N/R	57	$3,195
2021	N/R	33	$2,214
2022	N/R	88	$4,935
2023	N/R	65	$11,508
2024	N/R	70	$3,444

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	64	76	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	374	1,563	$83
99238	Hospital discharge day management, 30 minutes or less	77	100	$55
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	95	611	$35
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	381	1,649	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	16	441	$304,205
Lenalidomide	Lenalidomide	20	553	$304,128
Imatinib Mesylate	Imatinib Mesylate	59	1,769	$242,834
Promacta	Eltrombopag Olamine	22	660	$204,122
Calquence	Acalabrutinib Maleate	12	358	$185,188

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	36	$2,673
K0738	Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$426
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	22	$345

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	114	$2,327	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yusuf Khan Deshmukh, M.D.?

Tedicare shows public-source Medicare data for Yusuf Khan Deshmukh, M.D. (NPI 1972585883), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yusuf Khan Deshmukh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yusuf Khan Deshmukh, M.D.?

Yusuf Khan Deshmukh, M.D. is linked to ELIZABETHTOWN HEMATOLOGY-ONCOLOGY PLC (billing NPI 1730161688) in the available physician profile data.

Does Yusuf Khan Deshmukh, M.D. have Open Payments data?

Yusuf Khan Deshmukh, M.D. has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.